ZHANG Ling, XIE Hui, YAN Miao, et al. Effects of Kelong Capsule on Benign Prostatic Hyperplasia Rat Model and Nrf2/ARE Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(11): 87-91.
ZHANG Ling, XIE Hui, YAN Miao, et al. Effects of Kelong Capsule on Benign Prostatic Hyperplasia Rat Model and Nrf2/ARE Signaling Pathway[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(11): 87-91. DOI: 10.13422/j.cnki.syfjx.20181127.
Objective: To investigate the effect of Kelong capsule on testosterone-induced benign prostatic hyperplasia (BPH) and its antioxidant mechanism in rats. Method: Forty male SD rats were randomly divided into normal group
model group
low-dose Kelong capsule group (3.6 g·kg-1)
high-dose Kelong capsule group (7.2 g·kg-1) and nuclear factor E2-related factor 2(Nrf2) intervention group
n=8 in each group. Except the rats in normal group
all the other rats received subcutaneous injections of testosterone propionate (TP) to establish BPH models. Drugs were concomitantly administered by oral gavage for 4 weeks. Then the effects of different drugs on wet weight of the prostate and prostate index (PI) were observed
and haematoxylin-eosin (HE) staining was used to observe the morphological changes. The malondialdehyde (MDA) and glutathione (GSH) contents in serum were detected by enzyme-linked immunosorbent assay(ELISA) kit. The mRNA levels of Nrf2
oxygenase-1 (HO-1) and quinone oxidoreductase (NQO1) were determined with real time fluorescent quantitative polymerase chain reaction (Real-time PCR). Result: As compared with the normal group
the wet weight of prostate and PI were increased and the prostatic epithelial was proliferated in the model group; GSH content in serum was significantly reduced; and mRNA expression levels of Nrf2
HO-1 and NQO1 were also significantly reduced (P<0.05
P<0.01). As compared with the model group
Kelong capsule significantly decreased prostate index
ameliorated the histological changes
increased the content of GSH in serum(P<0.01)
and significantly up-regulated Nrf2
HO-1 and NQO1 mRNA levels (P<0.05
P<0.01). Conclusion: Kelong capsule could effectively inhibit the development of BPH
and low dose Kelong capsule could activate Nrf2/ARE signal pathway to increase the antioxidant capacity of the body.